Free Newsletter
Breakthrough speeds drug discovery, manufacturing
A chemistry professor at the University of Illinois at Urbana-Champagne says that an iron-based catalyst she developed with a colleague could be instrumental in making better drugs while speeding up the development process. The potential breakthrough, described in Science magazine, focuses on the use of the catalyst to make specific changes in a complex molecule, avoiding the need to synthesize a molecule from scratch. That could remove several steps in a process now needed in both discovery work as well as manufacturing. The catalyst is cheaper and more versatile than enzymes in modifying molecules, says professor Christina White. And the catalyst also offers the opportunity to work better with metabolites, which are used in the discovery process.
- read the report in MIT Technology Review
Related Articles:
Study outlines billions in potential R&D savings. Report
Where's the ROI on drug R&D budgets? Report
U.K. researchers tout new drug development model. Report
Is pharma's drug discovery model sustainable? Editorial
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: